These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 83502)

  • 21. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [1,25-dihydroxycholecalciferol: a hormonal form of vitamin D3].
    Schweiz Med Wochenschr; 1979 Oct; 109(38):1405-9. PubMed ID: 583366
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
    Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
    Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.
    Weisman Y; Eisenberg Z; Leib L; Harell A; Shasha SM; Edelstein S
    Br Med J; 1980 Sep; 281(6242):712-3. PubMed ID: 7427411
    [No Abstract]   [Full Text] [Related]  

  • 25. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
    Phillips ME; Havard J; Otterud B
    Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W; Graben N; Merguet P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intestinal calcium absorption in the early stage of renal insufficiency and the effect of 5,6-trans-25-OHCC].
    Werner E; Malluche HH; Ritz E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1305-7. PubMed ID: 611840
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of atorvastatin on renal function in patients with chronic renal failure.
    Cianciaruso B; Torraca S; Somma G; Pisani A; Sabbatini M
    Nephrol Dial Transplant; 2002 Oct; 17(10):1858-9. PubMed ID: 12271007
    [No Abstract]   [Full Text] [Related]  

  • 31. Deterioration of renal function in non-dialytic uraemics caused by 1 alpha (OH)D3 which was not attributable to hypercalcaemia.
    Yoshiyama N; Akiba T; Matsui N; Iwamoto H; Ogura M; Nakagawa S; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1980; 17():569-74. PubMed ID: 7243799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vitamin D and renal failure (author's transl)].
    Fuss M; Corvilain J
    Rev Med Brux; 1981 Apr; 2(4):441-5. PubMed ID: 7291796
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of metabolites and analogues of vitamin D in prospective renal transplant recipients.
    Cundy T; Kanis JA; Fraher L; Clemens TL; O'Riordan JL
    Clin Nephrol; 1981 May; 15(5):240-5. PubMed ID: 7018772
    [No Abstract]   [Full Text] [Related]  

  • 34. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: Role of the kidney in the metabolism of calciferol (vitamin D).
    Coburn JW; Norman AW
    Clin Nephrol; 1973; 1(5):273-83. PubMed ID: 4358418
    [No Abstract]   [Full Text] [Related]  

  • 36. The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone.
    DeLuca HF
    N Engl J Med; 1973 Aug; 289(7):359-65. PubMed ID: 4578017
    [No Abstract]   [Full Text] [Related]  

  • 37. Impairment of renal function in patients on 1alpha-hydroxycholecalciferol.
    Winterborn MH; Mace PJ; Heath DA; White RH
    Lancet; 1978 Jul; 2(8081):150-1. PubMed ID: 78344
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: vitamin-D metabolism in chronic renal failure.
    Wake CJ; Maddocks JL
    Lancet; 1975 Mar; 1(7905):516-7. PubMed ID: 46978
    [No Abstract]   [Full Text] [Related]  

  • 40. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
    Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
    Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.